Skip to content
GenoLensGenoLens

PHKG2

Chr 16p11.2

phosphorylase kinase catalytic subunit gamma 2

MANE:
ENST00000563588.6

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Glycogen storage disease

    BIALLELIC, autosomal or pseudoautosomal
  • Ketotic hypoglycaemia

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

  • Intellectual disability

Disease associations (Open Targets)

  • glycogen storage disease IXc

    0.74
  • glycogen storage disease due to liver phosphorylase kinase deficiency

    0.66
  • disorder of glycogen metabolism

    0.51
  • Glycogen storage disease due to glycogenin deficiency

    0.51
  • Glycogen storage disease due to phosphorylase kinase deficiency

    0.48
  • hereditary disease

    0.47
  • Parkinson disease

    0.36
  • neurodegenerative disease

    0.36
  • Alzheimer disease

    0.36
  • lysosomal storage disease

    0.36

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Phosphorylase b kinase gamma catalytic chain, liver/testis isoform

Catalytic subunit of the phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis) by phosphorylating and thereby activating glycogen phosphorylase. May regulate glycogeneolysis in the testis. In vitro, phosphorylates PYGM (PubMed:35549678)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.